Search

everythinglearnresearchcommunity

for

Search:↓

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Upadacitinib may effectively treat resistant lichen planopilaris.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Tazarotene gel may be more effective for acne than adapalene gel.